Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Greg Brigham

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Addiction Science & Clinical Practice|October 18, 2011
Response: thoughtfulness requiredGreg Brigham, Ron Jackson, Janet Wood
Drug and Alcohol Dependence|September 13, 2011
Addressing Tobacco Through Organizational Change (ATTOC) in residential addiction treatment settingsJoseph Guydish, Douglas Ziedonis, Barbara Tajima, et al.
Contemporary Clinical Trials|May 28, 2009
Brief strategic family therapy for adolescent drug abusers: a multi-site effectiveness studyMichael S Robbins, José Szapocznik, Viviana E Horigian, et al.
Journal of Substance Abuse Treatment|July 28, 2014
Is level of exposure to a 12-step facilitation therapy associated with treatment outcome?Elizabeth A Wells, Dennis M Donovan, Dennis C Daley, et al.
Addiction (Abingdon, England)|July 27, 2005
A multi-center randomized trial of buprenorphine-naloxone versus clonidine for opioid detoxification: findings from the National Institute on Drug Abuse Clinical Trials NetworkWalter Ling, Leslie Amass, Steve Shoptaw, et al.
Journal of Substance Abuse Treatment|February 26, 2008
Adverse events in an integrated trauma-focused intervention for women in community substance abuse treatmentTherese Killeen, Denise Hien, Aimee Campbell, et al.
The American Journal on Addictions|June 19, 2004
Bringing buprenorphine-naloxone detoxification to community treatment providers: the NIDA Clinical Trials Network field experienceLeslie Amass, Walter Ling, Thomas E Freese, et al.
Drug and Alcohol Dependence|September 23, 2008
Predictors of outcome for short-term medically supervised opioid withdrawal during a randomized, multicenter trial of buprenorphine-naloxone and clonidine in the NIDA clinical trials network drug and alcohol dependenceDouglas M Ziedonis, Leslie Amass, Marc Steinberg, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Addiction Science & Clinical Practice|October 18, 2011
Response: thoughtfulness requiredGreg Brigham, Ron Jackson, Janet Wood
Drug and Alcohol Dependence|September 13, 2011
Addressing Tobacco Through Organizational Change (ATTOC) in residential addiction treatment settingsJoseph Guydish, Douglas Ziedonis, Barbara Tajima, et al.
Contemporary Clinical Trials|May 28, 2009
Brief strategic family therapy for adolescent drug abusers: a multi-site effectiveness studyMichael S Robbins, José Szapocznik, Viviana E Horigian, et al.
Journal of Substance Abuse Treatment|July 28, 2014
Is level of exposure to a 12-step facilitation therapy associated with treatment outcome?Elizabeth A Wells, Dennis M Donovan, Dennis C Daley, et al.
Addiction (Abingdon, England)|July 27, 2005
A multi-center randomized trial of buprenorphine-naloxone versus clonidine for opioid detoxification: findings from the National Institute on Drug Abuse Clinical Trials NetworkWalter Ling, Leslie Amass, Steve Shoptaw, et al.
Journal of Substance Abuse Treatment|February 26, 2008
Adverse events in an integrated trauma-focused intervention for women in community substance abuse treatmentTherese Killeen, Denise Hien, Aimee Campbell, et al.
The American Journal on Addictions|June 19, 2004
Bringing buprenorphine-naloxone detoxification to community treatment providers: the NIDA Clinical Trials Network field experienceLeslie Amass, Walter Ling, Thomas E Freese, et al.
Drug and Alcohol Dependence|September 23, 2008
Predictors of outcome for short-term medically supervised opioid withdrawal during a randomized, multicenter trial of buprenorphine-naloxone and clonidine in the NIDA clinical trials network drug and alcohol dependenceDouglas M Ziedonis, Leslie Amass, Marc Steinberg, et al.
Pageof 1